ganism that was present in fecal specimens from two children and one adult; the organism was examined by bright-field microscopy and was found to resemble Isospora species [2] .
As with Cryptosporidium, Cyclospora is not a "new" organism but a newly recognized organism that is perhaps emerging as a pathogen. Cyclosporan organisms were first noted in the intestines of moles in 1870 by Eimer, and Schneider created the genus Cyclospora in 1881. In 1902, Schaudinn reported the first life-cycle study, which showed that Cyclospora caryolitica developed in the intestinal epithelia of moles and produced severe enteritis [14] . Cyclosporan species have subsequently been found in snakes, insectivores, and rodents.
Epidemiology
Cyclospora is widely distributed throughout the world; it has been identified in both residents and travelers from various regions including North America, Central America, and South America; the Caribbean islands; Eastern Europe; India; South Africa; and Southeast Asia. Persons of all ages have been infected. Most of the current knowledge of the epidemiology of Cyclospora species is derived primarily from Nepal, Haiti, and Peru because the parasite appears to be endemic in these countries.
Although epidemiological studies have differed in design and thus are not comparable, distinctly different patterns of infection have been described in the areas where the parasite is endemic (table 1) . In Kathmandu, Nepal, workers at two clinics for expatriates and tourists have documented an annual surge of cyclosporiasis that coincides with the rainy season (between May and October) [5, 15] . Because of this unique situation, several investigators have been able to conduct numerous large-scale clinical studies that have contributed significantly to our knowledge of the epidemiology, pathogenesis, and treatment of infections due to Cyclospora [5, [15] [16] [17] [18] [19] .
Prevalence rates of 11% have been documented among nonnative adults and children residing in Kathmandu during the rainy season [15] . In a case-control study of the indigenous population (i.e., Nepalese children), Hoge found that 5% of symptomatic children and 2% of asymptomatic children older than 18 months had cyclospora infection, whereas none of 74 children < 18 months of age were infected [16] . Over a 34-month period, Pape et al. [20] found that 11% of 450 HIV-infected Haitian adults with chronic diarrhea had cyclospora infection. However, none of 2,000 Haitian infants (mean age, <6 months) with diarrhea or 50 non-HIV-infected adults with diarrhea were found to have cyclosporiasis.
In two separate studies conducted in shantytowns outside Lima, Peru, Ortega et al. [11] found that 18% (26 subjects) and 6% (15 subjects) of children ranging in age from 1 month to >2 years had Cyclospora in their stool specimens. Nine of the 26 subjects in the first study and two of the 15 subjects in the second study presented with diarrhea.
Prevalence studies from Nepal, Haiti, and Peru suggest that, to date, symptomatic infection is more common in children older than 18 months but that younger children may have asymptomatic infection, and the rates of infection are lower among natives than among non-native residents (table 1) . Whether the differences in the distribution of symptomatic infections in different age groups and in various geographic areas are due to the acquisition of protective immunity, different exposures, different species or strains, the sensitivity of diagnostic techniques, or other as yet undescribed factors is not known.
Prevalence studies of cyclosporiasis have not been reported from the United States or other developed countries. However, surveys of 1,042 stool specimens received in laboratories in Chicago and 6,525 stool specimens received in laboratories in Burlington, Massachusetts, revealed Cyclospora in 0.5% and 0.3% of samples, respectively [9, 21, 22] ; this incidence is similar to that of isosporiasis. Similarly, in a survey of stool samples conducted in the United Kingdom, Cyclospora was identified in 0.1% of 1,333 samples [23] .
Although most reported cases of cyclosporiasis that have occurred outside Nepal, Haiti, and Peru have been linked to travel, it appears that documentation of infection in indigenous populations, both in the United States and abroad, is increasing [16, [24] [25] [26] . Whether this increase is due to more frequent recognition of the infection or a true change in its incidence is not known.
Before 1995, four or five cases of cyclosporiasis per year were diagnosed at the New York Hospital-Cornell Medical Center in New York, and all infections that were not in travelers occurred between May and August, consistent with the seasonality documented in Nepal. In May, June, and July of 1995, excess numbers of cyclospora infections, primarily in nontravelers, were documented in New York and Florida. Although eating unwashed berries was implicated as a risk factor, it could not be proven. Similar outbreaks are occurring once again in New York and Florida at the time of this writing. Investigations are currently being conducted to determine the sources of infection and whether these clusters are due to point source outbreaks, increased incidence, or increased recognition.
Whether cyclosporiasis is truly uncommon in the United States cannot be determined from the available data. Underdiagnosis of cyclospora infection may be due to the following factors: many physicians have never heard of the parasite; most clinical laboratories do not routinely include Cyclospora as part of the ova and parasite examination; shedding of Cyclospora in stool may be intermittent, as is the case with Isospora; and acid-fast staining, which is insensitive for the detection of Cryptosporidium species, may also be a relatively insensitive technique for detecting Cyclospora.
Two point source outbreaks of cyclosporiasis have been epidemiologically linked to contaminated water. In 1990, 21 employees, including house staff, who attended a party in a Chicago hospital dormitory developed diarrhea; 11 of these persons had documented cyclospora infection [27] . The stirring up of stagnant water in a storage tank after repair of a water pump is believed to have caused contamination of the implicated building's water supply. Although algae and diatoms were detected in the water, Cyclospora was not found.
An outbreak of diarrhea occurred in June 1994 among British soldiers and dependents stationed in a military detachment in Pokhara, Nepal; an investigation revealed Cyclospora oocysts in a 2-liter water sample taken from a storage tank that fed chlorinated, filtered water to all the homes in the area [19] . During the outbreak, chlorination was found to be adequate, and the water was free of coliforms. Thus, Cyclospora is resistant to chlorination, as is Cryptosporidium, and Cyclospora is not readily detected by methods that are currently used to assure the safety of drinking water supplies.
Data on the outbreaks of cyclospora infection in Chicago and Nepal provide compelling evidence that Cyclospora is acquired through contaminated water [15, 19, 27] . In a report of cyclosporiasis in a man from Utah, contaminated sewage that seeped into his home was implicated as a putative source of infection [28] . Transmission via contaminated food [29] , lettuce [15] , undercooked meat [2] , and raw beef [6] has been suggested but not proven. In Peru, four members of the same family who drank unchlorinated canal water developed cyclosporiasis; in addition, one of the ducks they bred was found to have asymptomatic cyclospora infection [30] .
Direct animal-to-human or person-to-person transmission of Cyclospora has not been documented. Reservoirs of infection have also not been identified. Although the seasonality of cyclospora infection is more pronounced than is that of cryptosporidium infection, characteristics of Cyclospora and/or host factors that contribute to this phenomenon have not been delineated.
Taxonomic and Morphological Features of Cyclospora
The genus Cyclospora is in the subclass Coccidia , phylum Apicomplexa. Thus, this genus is taxonomically related to four other coccidian genera that have been described as pathogens in humans: Cryptosporidium, Isospora, Toxoplasma, and Sarcocystis. The species name C. cayetanensis has been suggested by Ortega et al. [11, 31] and is derived from the Univcrsidad Peruana Cayetano Heredia in Lima, Peru, where studies of this parasite have been conducted . Whether more than one species of Cyclospora affects humans has not yet been determined,
The range of hosts for the Cyclospora species that have been identified in humans and animals is also not known. Cyclosporan species detected in insectivores , reptiles, and rodents are ovoid and slightly larger than the species identified in humans [32] .
Coccidia may complete their life cycle within a single host (Cryptosporidium species) or require a second host (Toxoplasma species) or a period of time outside the host for maturation (Isospora species) . Although the details of its life cycle in the human host have yet to be fully characterized, Cyclospora resembles Isospora in that oocysts are excreted unsporulated and require a period of time outside the host for maturation to occur. In the laboratory, sporulation occurs after a 5-11 day incubation in either distilled water or in 2.5% potassium dichromate at temperatures between 25"C and 32°C [11] .
Cyclospora oocysts are spherical and are 8-10 J.1m in diameter. When observed by means of light microscopy or phasecontrast microscopy, Cyclospora oocysts appear as nonrefractile spheres that contain a cluster of refractile membranebound globules [11, 31, 33] (figures I and 2). Electron microscopic studies reveal an outer fibrillar coat that is 63 nm thick and a cell wall that is 50 nm thick. Within each oocyst there are two sporocysts, each~4 pm in diameter with a cell wall that is 62 nm thick.
Two sporozoites are contained within each sporocyst; these sporozoites are 1.2 J.1m wide and 9.0 J.1m long and contain a membran e-bound nucleus and micronemes characteristic of the Apicomplexans [11, 31] . In contrast, the spherical Cryptosporidium oocyst is half the size of Cyclospora and contains four naked sporozoites, whereas the elliptical Isospora oocyst is much larger than that of Cyclospora and contains two sporocysts, each containing four sporozoites (table 2) (figure 3A, 3B, and 3C). 
Infection Due to Cyclospora
Clinical manifestations. The incubation period for cyclospora infection ranges from 2 to II days. In the Chicago outbreak the onset of illness may have occurred as early as 12-24 hours after exposure to the organism , whereas in Nepal, a patient was found to have Cyclospora oocysts in a stool sample before the onset of diarrhea [15, 27] .
Although cyclosporiasis is said to be clinically indistinguishable from cryptosporidiosis and isosporiasis , clinicians should be aware that diarrhea may not be the presenting or predominant symptom for patients who have cyclospora infection. Clinical manifestations of cyclosporiasis include watery diarrhea that occurs in a relapsing , cyclical pattern, sometimes alternating with constipation . Important associated symptoms include profound fatigue, "indigestion or heartburn"-like symptoms, nausea , abdominal cramps, anorexia , weight loss, and vomiting . A flulike prodrome with accompanying myalgias and arthralgias may precede the onset of diarrhea. Although the illness is self-limited , it may be prolonged and last for weeks; progressive fatigue, anorexia , and weight loss may overshadow the presenting diarrheal symptom s [9, 21, 24, 34, 35] .
Delay in diagnosis (which requires examination of a stool specimen) occurs often because upper gastrointestinal tract signs and symptoms and the symptoms of profound fatigue often predominate over the diarrheal symptoms by the time medical attention is sought. Abnormal xylose absorption has been documented in a small number of C)clospora-infectcd patients [10, 17] .
Among immunocompromised hosts, cyclospora infection has occurred primarily in HlV-infected individuals. Clinical illness due to Cyclospora in these patients, like that due to Cryptosporidium species, is prolonged and severe and is associated with a high rate of recurrence that can be attenuated with long-term suppressive therapy [20, 24] . In a recent report, Sifuentcs-Osornio ct al. [24] provided indirect evidence for biliary tract infection with Cyclospora in two patients with AIDS [24] . The life cycle of Cyclospora talpae in the liver and bile ducts of moles has been well characterized, indicating that this parasite may have tropism for these tissues [32] . Histopathology and pathogenesis. Histological studies of distal duodenal and jejunal aspirates and of biopsied tissues have provided evidence of the following characteristics of Cyclospora: it is a human pathogen; the upper small bowel is the site of infection in the immunocompetent host; infection is associated with pronounced histopathologic changes; and the parasite is intracellular [10, 17] . In their controlled study, Connor et al. [17] found inflammatory changes, villous atrophy, and crypt hyperplasia in jejunal tissue from patients with diarrhea and Cyclospora-positive stool specimens; however, these findings were not present in asymptomatic controls with negative stool specimens [17] .
With use of electron microscopy, Bendall et al. [10] showed that coccidial organisms were present inside vacuoles within the cytoplasm of epithelial cells in jejunal biopsy specimens [10] . This finding has recently been confirmed [36] (Y. R. Ortega, personal communication) and contrasts with the intranuclear location of Cyclospora in the small intestines of moles [37] . The pathological changes seen in patients with cyclospora infection are reminiscent of tropical sprue, and the possibility that the parasite may trigger the latter condition has been raised [10] . The pathogenic mechanisms by which Cyclospora causes clinical illness are unknown.
Diagnosis. The diagnosis of cyclospora infection is based on microscopic detection of oocysts in fecal specimens. Examination of wet mounts of fresh, unpreserved stool by means of bright-field microscopy reveals nonrefractile spheres that are 8-1 0 J.Lm in diameter and contain numerous refractile globules enclosed within membranes (figure 2). Like the oocysts of Cryptosporidium and Isospora, the oocysts of Cyclospora are acid fast and thus can be seen by using one of the many acidfast staining techniques, including the modified Ziehl-Nielsen stain or the Kinyoun acid-fast stain. Cyclospora cysts have a variable appearance (unstained, pink, or dark red) on acid-fast staining, which is a distinguishing feature of the parasite with some diagnostic usefulness ( figures 3A and 4) .
Despite their distinct characteristics, Cyclospora oocysts may be confused with Cryptosporidium oocysts unless their diameter is measured with a micrometer (figures 3A and 3B). Cyclospora oocysts are autofluorescent and appear as neonblue circles when examined with an ultraviolet fluorescence microscope fitted with a 365-nm excitation filter ( figure 5) ; this property appears to wane over time.
The relative sensitivity, specificity, and predictive values of the various techniques for diagnosing cyclospora infection arc not known. Whether persons infected with Cyclospora shed oocysts intermittently, as do those with isospora infection, is also unknown. It is important to underscore that the rudimentary nature of our diagnostic techniques may in part contribute to underrecognition of cyclospora infection.
In addition to being found in feces, Cyclospora has also been detected in jejunal aspirates and biopsy specimens by means of light microscopy and electron microscopy [10. 17. 36] .
Antibodies to Cyclospora have been detected in infected patients, and antibody titers have been shown to increase during convalescence [33] . The humoral immune response to cyclospora infection has not been characterized in patients with AIDS.
Treatment. Trimethoprim-sulfamethoxazole (TMP-SMZ) is the drug of choice for treating cyclospora infection; this has been demonstrated in anecdotal reports, in a large open-label study of HIV-infected patients in Haiti, and in a placebocontrolled trial in Nepal [18, 20, 38] . Pape et al. [20] successfully treated patients infected with HIV and Cyclospora with TMP-SMZ (160/800 mg) four times daily for 10 days, followed by secondary prophylaxis with TMP-SMZ (160/800 mg) three times weekly. Hoge et al. [18] showed that TMP-SMZ ern 1996;23 (September) (160/800 mg) taken twice daily for 7 days was statistically significantly better than placebo for treating cyclospora infection in an expatriate population in Nepal (P < .0001) [18] . It is noteworthy that cyclosporiasis appears to have emerged in Nepal at a time when, because of growing resistance, quinolones replaced TMP-SMZ for the treatment of bacterial enteritis [18] . Alternative effective therapeutic agents have not yet been identified.
The Future
Has Cyclospora been responsible for many of our previously undiagnosed cases of intestinal disease, or has it recently emerged as a pathogen in response to dramatic changes in our environment? Is this organism, which holds great fascination for parasitologists, a passing medical curiosity for the clinician?
The impact of this parasite in terms of enteric illness in different populations, especially children in the developing world, will be determined only if clinicians are aware of its existence. Current concern with cost-effectiveness and the streamlining of medical care must be balanced against our ability to successfully intervene in the spread of a disease that is often associated with significant morbidity in immunocompetent hosts as well as immunocompromised hosts.
Further studies are needed to identify the populations at risk for cyclospora infection; to delineate the modes of spread; to develop inexpensive, reliable diagnostic techniques; and to identify alternative, efficacious agents for therapy and prophylaxis. Only after such studies have been completed will we have a chance of understanding and perhaps conquering this parasite.
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